527 related articles for article (PubMed ID: 11117527)
1. Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators.
Lazennec G; Canaple L; Saugy D; Wahli W
Mol Endocrinol; 2000 Dec; 14(12):1962-75. PubMed ID: 11117527
[TBL] [Abstract][Full Text] [Related]
2. Functional interactions of peroxisome proliferator-activated receptor, retinoid-X receptor, and Sp1 in the transcriptional regulation of the acyl-coenzyme-A oxidase promoter.
Krey G; Mahfoudi A; Wahli W
Mol Endocrinol; 1995 Feb; 9(2):219-31. PubMed ID: 7776972
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of STAT5b transcriptional activity by ligand-activated peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma.
Shipley JM; Waxman DJ
Mol Pharmacol; 2003 Aug; 64(2):355-64. PubMed ID: 12869640
[TBL] [Abstract][Full Text] [Related]
4. Conserved amino acids in the ligand-binding and tau(i) domains of the peroxisome proliferator-activated receptor alpha are necessary for heterodimerization with RXR.
Gorla-Bajszczak A; Juge-Aubry C; Pernin A; Burger AG; Meier CA
Mol Cell Endocrinol; 1999 Jan; 147(1-2):37-47. PubMed ID: 10195690
[TBL] [Abstract][Full Text] [Related]
5. Regulation of energy metabolism by long-chain fatty acids.
Nakamura MT; Yudell BE; Loor JJ
Prog Lipid Res; 2014 Jan; 53():124-44. PubMed ID: 24362249
[TBL] [Abstract][Full Text] [Related]
6. Addition of peroxisome proliferator-activated receptor alpha to guinea pig hepatocytes confers increased responsiveness to peroxisome proliferators.
Macdonald N; Holden PR; Roberts RA
Cancer Res; 1999 Oct; 59(19):4776-80. PubMed ID: 10519382
[TBL] [Abstract][Full Text] [Related]
7. Fibrate and statin synergistically increase the transcriptional activities of PPARalpha/RXRalpha and decrease the transactivation of NFkappaB.
Inoue I; Itoh F; Aoyagi S; Tazawa S; Kusama H; Akahane M; Mastunaga T; Hayashi K; Awata T; Komoda T; Katayama S
Biochem Biophys Res Commun; 2002 Jan; 290(1):131-9. PubMed ID: 11779144
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
Peters JM; Zhou YC; Ram PA; Lee SS; Gonzalez FJ; Waxman DJ
Mol Pharmacol; 1996 Jul; 50(1):67-74. PubMed ID: 8700121
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism.
Latruffe N; Vamecq J
Biochimie; 1997; 79(2-3):81-94. PubMed ID: 9209701
[TBL] [Abstract][Full Text] [Related]
10. Regulation of peroxisome proliferator-activated receptor-alpha mRNA in rat liver.
Sterchele PF; Sun H; Peterson RE; Vanden Heuvel JP
Arch Biochem Biophys; 1996 Feb; 326(2):281-9. PubMed ID: 8611035
[TBL] [Abstract][Full Text] [Related]
11. Transactivation by PPAR/RXR heterodimers in yeast is potentiated by exogenous fatty acid via a pathway requiring intact peroxisomes.
Marcus SL; Miyata KS; Rachubinski RA; Capone JP
Gene Expr; 1995; 4(4-5):227-39. PubMed ID: 7787415
[TBL] [Abstract][Full Text] [Related]
12. A single amino acid change in the mouse peroxisome proliferator-activated receptor alpha alters transcriptional responses to peroxisome proliferators.
Hsu MH; Palmer CN; Griffin KJ; Johnson EF
Mol Pharmacol; 1995 Sep; 48(3):559-67. PubMed ID: 7565638
[TBL] [Abstract][Full Text] [Related]
13. Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development.
Kim MJ; Deplewski D; Ciletti N; Michel S; Reichert U; Rosenfield RL
Mol Genet Metab; 2001 Nov; 74(3):362-9. PubMed ID: 11708867
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor-beta signaling contributes to enhanced proliferation of hepatic stellate cells.
Hellemans K; Michalik L; Dittie A; Knorr A; Rombouts K; De Jong J; Heirman C; Quartier E; Schuit F; Wahli W; Geerts A
Gastroenterology; 2003 Jan; 124(1):184-201. PubMed ID: 12512042
[TBL] [Abstract][Full Text] [Related]
15. Transcription coactivator PBP, the peroxisome proliferator-activated receptor (PPAR)-binding protein, is required for PPARalpha-regulated gene expression in liver.
Jia Y; Qi C; Kashireddi P; Surapureddi S; Zhu YJ; Rao MS; Le Roith D; Chambon P; Gonzalez FJ; Reddy JK
J Biol Chem; 2004 Jun; 279(23):24427-34. PubMed ID: 15150259
[TBL] [Abstract][Full Text] [Related]
16. Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation.
Krogsdam AM; Nielsen CA; Neve S; Holst D; Helledie T; Thomsen B; Bendixen C; Mandrup S; Kristiansen K
Biochem J; 2002 Apr; 363(Pt 1):157-65. PubMed ID: 11903058
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the peroxisomal beta-oxidation-dependent pathway by peroxisome proliferator-activated receptor alpha and kinases.
Latruffe N; Cherkaoui Malki M; Nicolas-Frances V; Clemencet MC; Jannin B; Berlot JP
Biochem Pharmacol; 2000 Oct; 60(8):1027-32. PubMed ID: 11007938
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptors, coactivators, and downstream targets.
Qi C; Zhu Y; Reddy JK
Cell Biochem Biophys; 2000; 32 Spring():187-204. PubMed ID: 11330046
[TBL] [Abstract][Full Text] [Related]
19. Subtype- and response element-dependent differences in transactivation by peroxisome proliferator-activated receptors alpha and gamma.
Kassam A; Hunter J; Rachubinski RA; Capone JP
Mol Cell Endocrinol; 1998 Jun; 141(1-2):153-62. PubMed ID: 9723896
[TBL] [Abstract][Full Text] [Related]
20. Physiological and therapeutic roles of peroxisome proliferator-activated receptors.
Berger J; Wagner JA
Diabetes Technol Ther; 2002; 4(2):163-74. PubMed ID: 12079620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
